Zhejiang Medicine 관리

관리 기준 확인 3/4

Zhejiang Medicine CEO는 Chun Lei Lu, Jun2018 에 임명되었습니다 의 임기는 6.42 년입니다. 는 CN¥ 5.39M 가치에 해당하는 회사 주식의 0.035% 직접 소유합니다. 5.39M. 경영진과 이사회의 평균 재임 기간은 각각 3.4 년과 3.4 년입니다.

주요 정보

Chun Lei Lu

최고 경영자

CN¥2.8m

총 보상

CEO 급여 비율	n/a
CEO 임기	6.4yrs
CEO 소유권	0.04%
경영진 평균 재임 기간	3.4yrs
이사회 평균 재임 기간	3.4yrs

최근 관리 업데이트

Recent updates

CEO

Chun Lei Lu (57 yo)

6.4yrs

테뉴어

CN¥2,844,200

보상

Mr. Chun Lei Lu is President and Director of Zhejiang Medicine Co., Ltd. since June 15, 2018. He serves as Vice Chairman of Zhejiang Medicine Co., Ltd.since June 16, 2021. Mr. Lu was Executive Vice Presid...

리더십 팀

이름	위치	테뉴어	보상	소유권
Chun Lei Lu	President & Vice Chairman	6.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Hongwei Wang	Executive Vice President	6.4yrs	CN¥2.61m	0.019% CN¥ 3.0m
Huan Ming Yu	Vice President	9.4yrs	CN¥2.05m	0.042% CN¥ 6.3m
Jianhong Ping	Vice President	3.4yrs	CN¥1.90m	0.0052% CN¥ 793.1k
Yongbin An	Senior Manager	3.4yrs	CN¥2.24m	데이터 없음
Liping Liang	Senior Manager	3.4yrs	CN¥1.97m	0.0078% CN¥ 1.2m
Xiaoping Wang	Senior Manager	3.4yrs	CN¥2.10m	0.0052% CN¥ 793.1k
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Qirong Li	CFO & Financial Director	3.4yrs	CN¥1.22m	0.0052% CN¥ 793.1k
Guangshan Guo	Accounting Supervisor	no data	데이터 없음	데이터 없음
Minzhi Shao	Board Secretary	1.2yrs	데이터 없음	데이터 없음
Jin Lin Zhu	Vice President	9.4yrs	CN¥1.82m	0.036% CN¥ 5.6m

3.4yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 관리: 600216 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Chun Lei Lu	President & Vice Chairman	12.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Chun Bo Li	Chairman of the Board	21.4yrs	CN¥3.46m	0.0097% CN¥ 1.5m
Naiwei Chen	Independent Director	6.4yrs	CN¥120.00k	데이터 없음
Yizheng Qiu	Independent Director	3.4yrs	CN¥120.00k	데이터 없음
Zhenhua Chu	Director	3.4yrs	CN¥1.86m	0.0078% CN¥ 1.2m
Yuqing Yu	Director	3.4yrs	CN¥1.85m	0.0052% CN¥ 793.1k
Qing Xia	Independent Director	3.4yrs	CN¥120.00k	데이터 없음
Xiaoming Wu	Independent Director	2.9yrs	CN¥120.00k	데이터 없음
Zhong Liu	Vice Chairman	1.4yrs	데이터 없음	데이터 없음
Yiyuan Wu	Chief Supervisor	1.4yrs	데이터 없음	데이터 없음
Hongyu Cang	Director	1.4yrs	데이터 없음	데이터 없음

3.4yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 이사회: 600216 의 이사회는 경험(평균 재직 기간 3.4 년)으로 간주됩니다.

Zhejiang Medicine 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.55 (vs CN¥0.029 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Zhejiang Medicine Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Dividend reduced to CN¥0.15

Zhejiang Medicine Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 1Q 2023)

Zhejiang Medicine Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment improves as stock rises 18%

Zhejiang Medicine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.029 (vs CN¥0.10 in 3Q 2022)

Zhejiang Medicine Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.14 in 2Q 2022)

Zhejiang Medicine Co., Ltd. to Report First Half, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.25 in 2Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.30 in 2Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.75 (vs CN¥0.36 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥15.25

New 90-day low: CN¥12.75

New 90-day low: CN¥13.19

Third quarter earnings released

Third quarter earnings released

New 90-day low: CN¥14.55

Zhejiang Medicine Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

New 90-day low: CN¥15.44

New 90-day low - CN¥16.73

First half earnings released

Earnings released

Zhejiang Medicine Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령